Desk Alert · October 2026

Verified non-Chinese supply available.

Here, verified means initial desk screening has been completed; it is not final transaction approval.

The AntimonyCo desk has confirmed allocation across multiple documented, non-Chinese supply channels. Availability, specification, origin, pricing, and delivery remain subject to final commercial confirmation and buyer qualification.

Desk-qualified · Allocation on request
Full source and lot documentation is released only to qualified buyers under the applicable confidentiality process.
MaterialGrade / specificationVolumeCorridorStatus
Antimony OreVariable grade · independent assay per lotAllocation on requestSouth / Southeast AsiaAvailable
Antimony Ingot99.65% min Sb · lot documentationAllocation on requestSouth Asia / ASEANAvailable
Antimony Trioxide99.5% Sb2O3 min · specification on requestAllocation on requestSouth Asia / ASEANAvailable
Brass Scrap 70/30Honey / Pales · clean sorted300 MT spot · rolling availabilityMENA / Gulf to Jebel AliAvailable
Copper WireMillberry 99.9% Cu · Berry No.1Continuous, subject to confirmationMENA / Gulf to Jebel AliAvailable
High-Nickel AlloyXRF-confirmed per lot500-600 MT indicatedMENA / Gulf to Jebel AliInquiry only
Aluminium Scrap 80/20Min 80% Al · free of drossContinuous, subject to confirmationMENA / Gulf to Jebel AliAvailable

What qualified buyers receive

Origin and specification package under NDA, independent assay or XRF records per applicable lot, KlearRoute Decision Receipt options, and OGP physical verification when scoped.

How to inquire

Complete the buyer qualification form. The desk reviews company standing, end use, destination, volume, and compliance requirements before controlled disclosure.

See live lots and submit RFQ

This notice is not a binding offer. OGP is an affiliated verification provider within the KlearRoute ecosystem; its reports are not independent third-party inspections. The term "verified" describes completed initial desk screening and does not guarantee a transaction, future conduct, final assay, regulatory outcome, or continuing availability.